Piperazine estrone sulfate

CAS: 7280-37-7

Ref. 3D-FP143872

Información del producto

• Nombre: Piperazine estrone sulfate
• Sinónimos: ESTROPIPATE, (8Xi,13Xi)-17-Oxoestra-1,3,5(10)-Trien-3-Yl Hydrogen Sulfate - Piperazine (1:1), 17-Oxoestra-1,3,5(10)-Trien-3-Yl Hydrogen Sulfate - Piperazine (1:1), 3-Sulfatoxyestra-1,3,5(10)-trien-17-one piperazine salt, Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1), Estrone sulfate piperazine salt, Estrone, hydrogen sulfate, compd. with piperazine (1:1), Estropipate, Harmogen, Piperazine, compd. with 3-(sulfooxy)estra-1,3,5(10)-trien-17-one (1:1), Piperazine, compd. with estrone hydrogen sulfate (1:1), Sulestrex, Sulestrex piperazine

Descripción

Piperazine estrone sulfate is a drug used in the treatment of estrogen deficiency. It is a prodrug that is converted to estradiol benzoate in vivo. Piperazine estrone sulfate has been shown to have anti-inflammatory and anti-cancer properties and has been used as an experimental therapy for ovarian cancer. This drug also inhibits replication by binding to the DNA, which prevents transcription and replication of the cell's genetic material. Piperazine estrone sulfate has been shown to have a significant effect on weight gain and body mass index in women with hypoestrogenism, but may cause side effects such as nausea, vomiting, breast pain, headache, dizziness, depression, and vaginal dryness.

• Marca: Biosynth

Propiedades químicas

• Peso molecular: 436.57 g/mol
• Fórmula: C₁₈H₂₂O₅S•C₄H₁₀N₂
• Pureza: Min. 95%